DELIVERY ORDER
ExpiredMulti-yearHT942726FE116
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY
$1.8M
obligated · signed 3 months ago
OCTAPLASLG POWDER AUTHORIZED UNDER FDA EUA, TO ALSO INCLUDE:STERILE WATER FOR INJECTION,TRANSFUSION SET WITH FILTER (BLOOD SET),A TRANSFER SET,ALCOHOL SWABS, AND A VENTED SPIKE ADAPTER FOR BLOOD TYPE AB WITH MINIMUM 16 MONTHS OF REMAINING SHELF-LIFE.
Performance timeline
Start
Jul 14, 2026
End
Oct 12, 2026
with all options
Loading status
This contract has expired. A follow-on may have been awarded.
Search for new solicitations from Department of Defense.
OCTAPHARMA USA INC.
Contract HT942726FE116
UEI
FKJKNJVR1HV4
Parent Company
OCTAPHARMA USA INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$1,800,000
Base + Exercised Options
$1,800,000
Total Ceiling Value
$1,800,000
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
YES
NAICS
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 06
Awarding Agency
Funding Agency
Contract Vehicle
HT942525DE004
IDCDepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.